Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Milestone Scientific (MLSS) Equity Average (2016 - 2025)

Historic Equity Average for Milestone Scientific (MLSS) over the last 15 years, with Q3 2025 value amounting to $2.9 million.

  • Milestone Scientific's Equity Average fell 6118.93% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year decrease of 6118.93%. This contributed to the annual value of $6.9 million for FY2024, which is 2408.68% down from last year.
  • As of Q3 2025, Milestone Scientific's Equity Average stood at $2.9 million, which was down 6118.93% from $3.9 million recorded in Q2 2025.
  • Over the past 5 years, Milestone Scientific's Equity Average peaked at $18.4 million during Q2 2021, and registered a low of $2.9 million during Q3 2025.
  • Moreover, its 5-year median value for Equity Average was $8.6 million (2023), whereas its average is $10.3 million.
  • In the last 5 years, Milestone Scientific's Equity Average soared by 146137.87% in 2021 and then crashed by 6118.93% in 2025.
  • Over the past 5 years, Milestone Scientific's Equity Average (Quarter) stood at $16.3 million in 2021, then crashed by 33.56% to $10.8 million in 2022, then crashed by 30.57% to $7.5 million in 2023, then fell by 13.0% to $6.5 million in 2024, then tumbled by 54.88% to $2.9 million in 2025.
  • Its Equity Average was $2.9 million in Q3 2025, compared to $3.9 million in Q2 2025 and $5.1 million in Q1 2025.